A Case of Recurrent Atypical Anti-Glomerular Basement Membrane Nephritis Suspicion after Renal Transplantation

Atypical anti-glomerular basement membrane (GBM) nephritis is a rare variant of the classical anti-GBM antibody disease. Patients present with an undetectable anti-GBM antibody but show linear glomerular basement membrane staining for immunoglobulin. We present a 69-year-old man who underwent a living-donor kidney transplant. The aetiology of the renal failure was a focal segmental glomerulonephritis-like lesion resistant to immunosuppressive therapy. A renal graft biopsy revealed diffuse endocapillary hypercellularity, and mild mesangiolysis with linear GBM staining for IgG. The patient was diagnosed with atypical anti-GBM nephritis since the patient tested negative for circulating anti-GBM antibodies. Treatment involved intravenous methylprednisolone, plasma exchange, and rituximab administration. Protocol graft biopsy performed 1 year after the renal transplant showed a focal segmental glomerulonephritis-like lesion possibly progressing from endocapillary hypercellularity and mesangiolysis. These findings were similar to his native kidney biopsy findings. Although classical recurrent anti-GBM nephritis is rare when a renal transplant is performed after decreased disease activity, this case was considered as a case of recurrent atypical anti-GBM nephritis after renal transplant.

[1]  S. Nasr,et al.  The clinicopathologic characteristics and outcome of atypical anti-glomerular basement membrane nephritis. , 2016, Kidney international.

[2]  A. Fogo Causes and pathogenesis of focal segmental glomerulosclerosis , 2015, Nature Reviews Nephrology.

[3]  J. Mölne,et al.  Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  David W. Johnson,et al.  Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease. , 2013, Kidney international.

[5]  H. Anders,et al.  Loss of a renal graft due to recurrence of anti‐GBM disease despite rituximab therapy , 2009, Clinical transplantation.

[6]  J. Nagy,et al.  [Focal segmental glomerulosclerosis]. , 2008, Orvosi hetilap.

[7]  O. Decaux,et al.  Alveolar Hemorrhage in Anti-Basement Membrane Antibody Disease: A Series of 28 Cases , 2007, Medicine.

[8]  F. Fervenza,et al.  Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  D. Cattran,et al.  Recurrence of anti-GBM disease 8 years after renal transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  A. George,et al.  Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  A. Rees,et al.  Anti-Glomerular Basement Membrane Disease , 2020, Definitions.

[12]  J. Levy,et al.  Recurrent glomerulonephritis following renal transplantation. , 1997, Transplantation.

[13]  J. Wieslander,et al.  Anti-GBM antibodies in Goodpasture syndrome; anatomy of an epitope. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.